Nouvelle déclaration d'incident
No de la demande: 2013-7065
Numéro de référence du titulaire d'homologation: PROSAR case: 1-35564062
Nom du titulaire (nom légal complet, aucune abbréviation): Syngenta Canada Inc.
Adresse: 140 Research Lane, Research Park
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G4Z3
Incident chez un animal domestique
Pays: CANADA
État: ONTARIO
Inconnu
ARLA No d'homologation 30864 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Lumex EZ
Oui
Inconnu
Site: Agricultural-Outdoor/Agricole-extérieur
Specify Type: Unknown
Inconnu
Professionnel de la santé
Cat / Chat
Unknown
1
Inconnu
Inconnu
Inconnu
Inconnu
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Oui
Inconnu
Unknown/Inconnu
Other / Autre
préciser Exposure was not witnessed but caller was concerned that the cats may have had access to the treated area.
(p.ex. description des symptômes tels que la fréquence et la gravité
1-35564062 - The reporter, a veterinarian, indicated that three cats may have been exposed to an herbicide containing the active ingredients s-metolachlor, atrazine and Mesotrione. The reporter indicated that two of her mother-in-laws cats (Subform III #1 and #2) had become ill with ocular discharge, nasal congestion, lethargy and inappetance approximately two to four days prior to initial contact with the registrant. The reporter had treated one of these cats (Subform III #1) with an injection of Convenia and subcutaneous fluids. At the time of the initial call the other cat (Subform III #2) was missing but once found the reporter intended to provide the same treatment. The reporter also stated that there was a third cat (Subform III #3) that seemed to be a little ill. Although exposure to the application site was not witnessed, the reporter indicated that the cats all had free access to the outdoors and while walking around the pet owner's home the reporter noted a sign stating the area was an experimental testing site for Syngenta products. The reporter was calling to determine which products were applied to the site to determine if exposure to the application site might be the cause for the illness of the cats. The active ingredients that had been used at the testing site were provided and the reporter was advised that the described symptoms may be consistent with an upper respiratory infection secondary to a herpes virus or calici virus infection. No further information is available.
Mineure
Professionnel de la santé
Cat / Chat
Unknown
1
Inconnu
Inconnu
Inconnu
Inconnu
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Inconnu
Inconnu
Unknown/Inconnu
Other / Autre
préciser Although no exposure was witnessed the caller was concerned that the cat may have had access to the application site.
(p.ex. description des symptômes tels que la fréquence et la gravité
1-35564062 - The reporter, a veterinarian, indicated that three cats may have been exposed to an herbicide containing the active ingredients s-metolachlor, atrazine and Mesotrione. The reporter indicated that two of her mother-in-laws cats (Subform III #1 and #2) had become ill with ocular discharge, nasal congestion, lethargy and inappetance approximately two to four days prior to initial contact with the registrant. The reporter had treated one of these cats (Subform III #1) with an injection of Convenia and subcutaneous fluids. At the time of the initial call the other cat (Subform III #2) was missing but once found the reporter intended to provide the same treatment. The reporter also stated that there was a third cat (Subform III #3) that seemed to be a little ill. Although exposure to the application site was not witnessed, the reporter indicated that the cats all had free access to the outdoors and while walking around the pet owner's home the reporter noted a sign stating the area was an experimental testing site for Syngenta products. The reporter was calling to determine which products were applied to the site to determine if exposure to the application site might be the cause for the illness of the cats. The active ingredients that had been used at the testing site were provided and the reporter was advised that the described symptoms may be consistent with an upper respiratory infection secondary to a herpes virus or calici virus infection. No further information is available.
Mineure
Professionnel de la santé
Cat / Chat
Unknown
1
Inconnu
Inconnu
Inconnu
Inconnu
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Inconnu
Inconnu
Unknown/Inconnu
Other / Autre
préciser Although no exposure was witnessed the caller was concerned that the cat may have had access to the application site.
(p.ex. description des symptômes tels que la fréquence et la gravité
1-35564062 - The reporter, a veterinarian, indicated that three cats may have been exposed to an herbicide containing the active ingredients s-metolachlor, atrazine and Mesotrione. The reporter indicated that two of her mother-in-laws cats (Subform III #1 and #2) had become ill with ocular discharge, nasal congestion, lethargy and inappetance approximately two to four days prior to initial contact with the registrant. The reporter had treated one of these cats (Subform III #1) with an injection of Convenia and subcutaneous fluids. At the time of the initial call the other cat (Subform III #2) was missing but once found the reporter intended to provide the same treatment. The reporter also stated that there was a third cat (Subform III #3) that seemed to be a little ill. Although exposure to the application site was not witnessed, the reporter indicated that the cats all had free access to the outdoors and while walking around the pet owner's home the reporter noted a sign stating the area was an experimental testing site for Syngenta products. The reporter was calling to determine which products were applied to the site to determine if exposure to the application site might be the cause for the illness of the cats. The active ingredients that had been used at the testing site were provided and the reporter was advised that the described symptoms may be consistent with an upper respiratory infection secondary to a herpes virus or calici virus infection. No further information is available.
Mineure